10-Q: NuScale Power Reports Q1 2024 Results, Navigates Transition to Commercialization

NuScale Power's Q1 2024 results reflect a decrease in revenue and increased operating losses as the company transitions from research and development to commercialization.

Summary

• NuScale Power Corporation reported a net loss of $48.1 million for the first quarter of 2024, compared to a net loss of $35.6 million in the same period of 2023.
• Revenue decreased to $1.4 million from $5.5 million year-over-year, primarily due to the termination of the contract with CFPP LLC.
• Research and development expenses decreased to $13.2 million from $27.6 million, while general and administrative expenses increased to $19.4 million from $14.7 million.
• The company's cash and cash equivalents stood at $132 million as of March 31, 2024, with $5.1 million in restricted cash.
• NuScale implemented a workforce reduction of 154 employees in January 2024, resulting in a one-time charge of $3.2 million.
• The company is actively negotiating with potential customers to secure revenue-producing contracts and plans to implement phased cost reductions if needed.
• NuScale expects the NRC to complete its review and grant SDA approval by July 31, 2025.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is making progress in its commercialization efforts and has a plan to manage costs, the significant decrease in revenue and increase in net loss are concerning. The ongoing legal proceedings and reliance on future customer contracts add to the uncertainty.

Positives

• Research and development expenses decreased by $14.4 million year-over-year, indicating a shift away from R&D and towards commercialization.
• The company has $132 million in cash and cash equivalents, providing a financial buffer for operations.
• NuScale is actively pursuing new customer contracts, which could lead to future revenue growth.
• The company has a plan for phased cost reductions, demonstrating a proactive approach to managing expenses.
• The NRC is expected to complete its review of the SDA application by July 31, 2025, which is a key milestone for commercialization.

Negatives

• The net loss increased to $48.1 million in Q1 2024 from $35.6 million in Q1 2023.
• Revenue decreased significantly to $1.4 million from $5.5 million year-over-year.
• General and administrative expenses increased by $4.7 million, partially offsetting the decrease in R&D expenses.
• The company incurred a one-time charge of $3.2 million due to a workforce reduction.
• The loss of the CFPP LLC contract has significantly impacted revenue and cost share agreements.

Risks

• The company's ability to secure new customer contracts is critical for future revenue and profitability.
• Delays in the NRC's SDA approval process could impact the company's commercialization timeline.
• The company's financial performance is dependent on its ability to manage expenses and secure additional funding.
• The company is subject to various legal proceedings, which could result in financial liabilities.
• Failure to initiate commercial operation of NPM 1 could result in the DOE demanding repayment of fees invoiced for NPMs 2-6.

Future Outlook

The company expects operating losses and negative operating cash flow to continue until the commercialization of the NPM. Management believes they will have sufficient funds to cover R&D and operating cash needs for the next twelve months. The company is focusing on securing revenue-producing commercial contracts and plans to implement phased cost reductions if needed.

Management Comments

• Management is currently in active negotiations with potential customers to secure revenue producing contracts.
• Should the execution of customer contracts or capital raising activities be delayed, management plans to implement a phased cost reduction program, within our control, to reduce cash outflows, as needed.
• As a result of these plans, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months.

Industry Context

The report reflects the challenges faced by companies in the advanced nuclear technology sector as they transition from research and development to commercialization. The loss of the CFPP LLC contract highlights the risks associated with early-stage customer agreements. The company's focus on securing new contracts and managing costs is consistent with the broader industry trend of moving towards commercial viability.

Comparison to Industry Standards

• NuScale's financial results are not directly comparable to established nuclear power plant operators, as it is still in the pre-commercialization phase.
• The decrease in R&D spending is a typical trend for companies transitioning to commercialization, similar to other technology startups.
• The increase in G&A expenses is also common as companies scale up their operations and marketing efforts.
• The company's reliance on government funding and cost-share agreements is a common practice in the nuclear industry, particularly for innovative technologies.
• The ongoing legal proceedings are not uncommon for companies involved in complex transactions and emerging technologies.
• The company's cash position is relatively strong compared to other pre-revenue companies in the sector, but it will need to secure additional funding to support long-term operations.

Management Changes

Legal Proceedings

• Thirteen purported members of NuScale LLC filed a lawsuit against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC, related to the Merger.
• Two shareholder class action lawsuits were filed against the company and certain members of management, alleging materially false and/or misleading statements and failure to disclose material adverse facts.
• The company does not believe that resolution of any of these matters will materially affect the company's financial position or results of operations.

Related Party Transactions

• NuScale incurred expenses of $247 and $8,726 with Fluor for the three months ended March 31, 2024 and 2023, respectively.
• NuScale owes Fluor $380 and $4,080 as of March 31, 2024 and December 31, 2023, respectively.
• Fluor owes NuScale $189 and $2,642 as of March 31, 2024 and December 31, 2023, respectively.
• NuScale recognized no revenue from Fluor during the three months ended March 31, 2024, while during the same period in the prior year, NuScale earned revenue of $4,014.

Stakeholder Impact

• Shareholders are impacted by the increased net loss and decreased revenue.
• Employees were impacted by the workforce reduction of 154 employees.
• Customers are impacted by the termination of the CFPP LLC contract.
• Suppliers may be impacted by the company's cost reduction measures.
• Creditors are impacted by the company's financial performance and ability to repay debts.

Next Steps

• The company will continue to pursue new customer contracts.
• Management plans to implement a phased cost reduction program if needed.
• The company will continue to work with the NRC to obtain SDA approval.
• The company will manage its expenses and cash reserves prudently.

Key Dates

Keywords

small modular reactor, SMR, NuScale Power, nuclear power, financial results, commercialization, NRC, design certification, cost share, workforce reduction